AMGEN Kyprolis recall: Sterility Concern
AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for…
Why was AMGEN Kyprolis recalled?
Lack of Assurance of Sterility: Potential cracks in glass vials
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #1071559, 1071629; Exp. 05/18
- Product
- AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for…
- Recalling firm
- Amgen, Inc.
- Quantity
- 11,434 vials
- Distribution
- United States and Puerto Rico No foreign distribution.
- Recall date
- December 28, 2016
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)